학술논문

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Document Type
Article
Source
Lancet Respiratory Medicine; Sep2023, Vol. 11 Issue 9, p791-803, 13p
Subject
REMDESIVIR
RESPIRATORY insufficiency
COVID-19
EXTRACORPOREAL membrane oxygenation
NONINVASIVE ventilation
Language
ISSN
22132600
Abstract
Copyright of Lancet Respiratory Medicine is the property of Lancet and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)